JPRN-UMIN000027714已完成未知
Analysis of serum epithelium mesenchymal system marker for advanced or metastatic breast cancer treated with Eribulin - Analysis of serum epithelium mesenchymal system marker for advanced or metastatic breast cancer treated with Eribulin
Breast Surgery, Osaka Medical College0 个研究点目标入组 30 人开始时间: 2017年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. serious complication or past history: with symptomatic heart failure, ischemic heart disease within 6 months, liver cirrhosis, psychological disorder treated by antipsychotic drug, uncontrolable diabetes, etc 2. active infection 3. The anamnesis of the hypersensitivity to Eribulin 4. peripheral neuropathy greater than Grade 3 5. male breast cancer 6. under pregnancy or breast-feeding, and possibility (will) of pregnancy. 7. with doctors decision for exclusion
研究者
相似试验
进行中（未招募）
1 期
Cutaneous analysis after cells from adipose tissue applied in human face20 Health patients presenting photo aged skinG13.750.829.826RBR-2nn9y2universidade federal do rio de janeiro
已完成
不适用
An immunohistochemical analysis of epithelial-to-mesenchymal transition associating molecules for the patients of pulmonary sarcomatoid carcinoma.on-small cell lung cancerJPRN-UMIN000008737First department of internal medicine, Kansai Medical University.28
尚未招募
Unknown
RELATING BIOMARKER EXPRESSION TO LYMPH NODAL INVOLVEMENT IN CARCINOMA BREASTCTRI/2024/01/061365Kanmathareddy Amulya
进行中（未招募）
不适用
EMT markers expression in oral cancersCTRI/2020/11/029361AIIMS Rishikesh
尚未招募
不适用
TO STUDY ROLE OF EPITHELIAL MESENCHYMAL TRANSITION MARKER IN ORAL CANCERCTRI/2021/08/035485AIIMS RISHIKESH